SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-403316
Filing Date
2014-11-07
Accepted
2014-11-07 16:06:56
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d804161d10q.htm 10-Q 626942
2 EX-31.1 d804161dex311.htm EX-31.1 7654
3 EX-31.2 d804161dex312.htm EX-31.2 7661
4 EX-32.1 d804161dex321.htm EX-32.1 2805
5 EX-32.2 d804161dex322.htm EX-32.2 2819
  Complete submission text file 0001193125-14-403316.txt   4657241

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agio-20140930.xml EX-101.INS 615086
7 XBRL TAXONOMY EXTENSION SCHEMA agio-20140930.xsd EX-101.SCH 41342
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agio-20140930_cal.xml EX-101.CAL 59155
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agio-20140930_def.xml EX-101.DEF 141170
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20140930_lab.xml EX-101.LAB 379715
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20140930_pre.xml EX-101.PRE 263977
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 141204975
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences